Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 14/20 | 0.70 |
| ▸ | HSP90AB1 | P08238 | 14/20 | 0.70 |
| ▸ | ERBB2 | P04626 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2604975 | 0.82 | HSP90AA1 (1.00) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL14456059 | 0.81 | HSP90AA1 (0.72) | HSP90AA1HSP90AB1ERBB2MEN1SLC22A1 | |
| SCHEMBL17900222 | 0.81 | HSP90AA1 (0.68) | HSP90AA1HSP90AB1ERBB2MEN1SLC22A1 | |
| SCHEMBL10149976 | 0.77 | HSP90AA1 (0.89) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL17897955 | 0.75 | HSP90AA1 (0.61) | HSP90AA1HSP90AB1ERBB2MEN1SLC22A1 | |
| SCHEMBL17900416 | 0.75 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1ERBB2MEN1SLC22A1 | |
| SCHEMBL1964163 | 0.74 | HSP90AA1 (0.86) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL14044861 | 0.73 | HSP90AA1 (0.83) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL17897956 | 0.70 | HSP90AA1 (0.60) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL4855740 | 0.69 | HSP90AA1 (0.74) | HSP90AA1HSP90AB1ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260143662-A1 | SEMICONDUCTOR STRUCTURE AND METHOD OF FORMING THEREOF | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-05-21 | — | — | US | disclosed |
| US-12600725-B2 | Selective GRP94 inhibitors and uses thereof | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260082532-A1 | SEMICONDUCTOR STRUCTURE AND METHOD FOR FORMING THE SAME | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-03-19 | — | — | US | disclosed |
| US-20250374504-A1 | SEMICONDUCTOR STRUCTURE AND FORMING METHOD THEREOF | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-12-04 | — | — | US | disclosed |
| US-20250358997-A1 | MEMORY DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-11-20 | — | — | US | disclosed |
| CN-119907742-A | Easy-to-adhere polyester film | 东洋纺株式会社 | 2025-04-29 | — | — | CN | disclosed |
| EP-3532545-B2 | POLYURETHANE RESIN FOR INK JET INK | AGFA NV (BE) | 2025-03-12 | — | — | EP | disclosed |
| US-20250056784-A1 | MEMORY DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-13 | — | — | US | disclosed |
| CN-119371628-A | Acetal structure-containing acid enzyme-controllable degradable polyurethane and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2025-01-28 | — | — | CN | disclosed |
| CN-119192522-A | Multifunctional synergistic antifouling degradable polyurethane resin and preparation method and application thereof | 华南理工大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-110177818-B | Polyurethane-based adhesive dispersions | 惠普发展公司，有限责任合伙企业 | 2022-04-08 | — | — | CN | disclosed |
| EP-3532545-B1 | POLYURETHANE RESIN FOR INK JET INK | AGFA NV (BE) | 2022-03-16 | — | — | EP | disclosed |
| US-20220073773-A1 | FLUID SET | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-03-10 | — | — | US | disclosed |
| US-11267816-B2 | Selective Grp94 inhibitors and uses thereof | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-03-08 | — | — | US | disclosed |
| CN-113444220-B | Isosorbide-based antibacterial self-healing polyurethane and preparation method and application thereof | 宁波昌亚新材料科技股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-111072973-B | Phosphorus-containing POSS, preparation method thereof and application thereof in flame retardant | 杭州师范大学 | 2022-02-01 | — | — | CN | disclosed |
| US-20200102312-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2020-04-02 | — | — | US | disclosed |
| US-10421758-B2 | Selective Grp94 inhibitors and uses thereof | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2019-09-24 | — | — | US | disclosed |
| US-20160194328-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2016-07-07 | — | — | US | disclosed |
| US-20160194328-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194328-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | HSP90B1, HSP90AB2P, HSPE1 | HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885 |
| US-10421758-B2 | Selective Grp94 inhibitors and uses thereof | HSP90B1, HSP90AB2P, HSPE1 | HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885 |
| US-20260082532-A1 | SEMICONDUCTOR STRUCTURE AND METHOD FOR FORMING THE SAME | CTCF, LCK, ORAI2 | HSP90AA1 4656/4885HSP90AB1 4695/4885ERBB2 398/4885 |
| US-20260143662-A1 | SEMICONDUCTOR STRUCTURE AND METHOD OF FORMING THEREOF | CD47, EPCAM, SMC2 | HSP90AA1 4865/4885HSP90AB1 4867/4885ERBB2 951/4885 |
| US-11267816-B2 | Selective Grp94 inhibitors and uses thereof | HSP90B1, HSP90AB2P, HSPE1 | HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885 |
| US-12600725-B2 | Selective GRP94 inhibitors and uses thereof | GRPR, HSPB1, HSP90AB2P | HSP90AA1 14/4885HSP90AB1 8/4885ERBB2 402/4885 |
| US-20200102312-A1 | SELECTIVE GRP94 INHIBITORS AND USES THEREOF | HSP90B1, HSP90AB2P, HSPE1 | HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.